Antioxidant capacity and oxygen radical diseases in the preterm newborn

Archives of Pediatrics and Adolescent Medicine

Volumn 154, Issue 6, 2000, Pages 544-548

  Rogers, Samuel ^a   Witz, Gisela ^b   Anwar, Mujahid ^a   Hiatt, Mark ^a   Hegyi, Thomas ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CORRELATION FUNCTION; HUMAN; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NEWBORN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA;

EID: 0034129751     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.154.6.544     Document Type: Article

References (24)

1. Saugstad OD. Hypexanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988:23:143-150.
2. Abdel-Rahman AM, Rosenberg AA. Prevention of intraventricular hemorrhage in the premature infant. Clin Perinatol. 1994;21:505-521.
3. Lucey JF, Dangman B. A reexamintion of the role of oxygen in retrolentat fibroplasia. Pediatrics. 1984;73:82-96.
4. Crissinger KD. Regulation of hemodynamics and oxygenation in developing intestine insight into the pathogenesis of necrotizing enterocolitis. Acta Paediatr Suppl. 1994;396:8-10.
5. Saugstad O. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr. 1997;86:1277-1282.
6. Miller NJ, Rice-Evans C. Davies MJ, Gopinathan V. Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status of premature neonates. Clin Sci. 1993;84:407-412.
7. Papiie L-A, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529-534.
8. International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Pediatrics. 1988;82:37-43.
9. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 1994;349:197-200.
10. Drury JA, Nycyk JA, Baines M. Cooke RWI. Does total antioxidant status relate to outcome in very preterm infants? Clin Sci. 1998;94:197-201.
11. Bélanger S, Lavoie J-C, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biol Neonate. 1997;71:233-238.
12. Sullivan JL, Newton RB. Serum antioxidant capacity in neonates. Arch Dis Child. 1988;63:748-757.
13. Silvers KM, Gibson AT, Russel JM, Powers HJ, Antioxidant activity, packed cell transfusions, and outcome in premature infants. Arch Dis Child Fetal Neonatal Ed. 1998;78:F214-F219.
14. Lindeman JHN, van Zoeren-Grobben D, Schrijver J, Speek AJ, Poorthuis BJHM, Berger HM. The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatr Res. 1989;26:20-24.
15. Schlenzig J-S, Bervoets K, von Loewenich V, Böhles H. Urinary malondialdehyde concentration in preterm neonates: is there a relationship to disease entities of neonatal intensive care? Acta Paediatr 1993;82:202-205.
16. Inder TE, Darlow BA, Sluis KB, et al. The correlation of elevated levels of an index of lipid peroxidation (MDA-TBA) with adverse outcome in very low birthweight infants. Acta Paediatr. 1996;85:1116-1122.
17. Varsila E, Pitkänen O, Hallman M, Andersson S. Immaturity-dependent free radical activity in premature infants. Pediatr Res. 1994;36:55-59.
18. Nycyk JA, Drury JA, Cooke RWI. Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998; 79:F67-F69.
19. Varsila E, Pesonen E. Andersson S. Early protein oxidation in the neonatal lung is related to the development of chronic lung disease. Acta Paediatr. 1995;84: 1296-1299.
20. Ogihara T, Okamoto R, Han-suk K, et al. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res. 1996; 39:117-119.
21. Pitkänen OM, Hallman M, Andersson SM. Correlation of free radical-induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr. 1990;116:760-764.
22. Moison RMW, de Beaufort A-J, Haasnoot AA, Dubbelman TMAR, van ZoerenGrobben D, Berger HM. Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic Biol Med. 1997;23:226-234.
23. Schrod L, Neuhaus T, Speer CP, Girschick H, Possible role of uric acid as an antioxidant in premature infants. Biol Neonate. 1997;72:102-111.
24. Moison RMW, Haasnoot AA, van Zoeren-Grobben D, Berger HM, Plasma proteins in acute and chronic lung disease of the newborn. Free Radic Biol Med. 1998;25:321-328.